Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;22(3):208-10.
doi: 10.1097/MOO.0000000000000042.

Sublingual immunotherapy: what we can learn from the European experience

Gary Linkov  1 , Elina Toskala
Affiliations
Review

Sublingual immunotherapy: what we can learn from the European experience

Gary Linkov et al. Curr Opin Otolaryngol Head Neck Surg. 2014 Jun.

Abstract

Purpose of review: To review the recent European studies on sublingual immunotherapy (SLIT). SLIT is currently widely used in Europe and is gaining popularity in the United States.

Recent findings: Longer treatment with SLIT compared with subcutaneous immunotherapy (SCIT) is needed to reduce the rhinitis symptoms in house dust mite (HDM) allergic children. SLIT appears to be well tolerated and effective for treating rhinitis and asthma in children, adults, and the elderly. Studies on HDM, grass, and ragweed have demonstrated posttreatment efficacy in both monosensitized and polysensitized patients.

Summary: SLIT has been shown to be an effective treatment for airway allergies, and recent studies give support for the use of SLIT as the first choice for allergy treatment compared with medication and SCIT. The use of SLIT may potentially improve the compliance of allergen immunotherapy and may make allergy treatment more accessible and well tolerated.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles